Board of Scientific Counselors, Coordinating Center for Health Promotion (BSC, CCHP), 27805 [E9-13692]
Download as PDF
Federal Register / Vol. 74, No. 111 / Thursday, June 11, 2009 / Notices
This notice is corrected as follows: On
page 26704 first column, under
SUMMARY, the Web site should read:
https://wwwn.cdc.gov/publiccomments/.
Dated: June 4, 2009.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–13694 Filed 6–10–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jlentini on PROD1PC65 with NOTICES
Name of Committee: National Institute of
General Medical Sciences; Initial Review
Group Minority Programs Review,
Subcommittee B.
Date: July 9–10, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Rebecca H. Johnson, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, Bethesda,
MD 20892. 301–594–2771.
Johnsonrhnigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
27805
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Centers for Disease Control and
Prevention
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; MBRS SCORE.
Date: July 9, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN12, 45 Center
Drive, Bethesda, MD 20892 (Telephone
Conference Call)
Contact Person: Arthur L. Zachary, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN–12, Bethesda,
MD 20892, (301) 594–2886,
zacharya@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: June 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–13758 Filed 6–10–09; 8:45 am]
BILLING CODE 4140–01–M
Board of Scientific Counselors,
Coordinating Center for Health
Promotion (BSC, CCHP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.–5 p.m., July 1,
2009.
Place: CDC, 1825 Century Boulevard, NE.,
Room 1042, Atlanta, Georgia 30345.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people.
Purpose: This BSC is charged with
providing advice and guidance to the
Secretary of Health and Human Services, the
Director of CDC, and the Director of CCHP
concerning strategies and goals for the
programs and research within the National
Center on Birth Defects and Developmental
Disabilities and the National Center for
Chronic Disease Prevention and Health
Promotion.
Matters To Be Discussed: The agenda will
include a review and discussion of charges
to the BSC Work Groups. The Work Group
projects include strategic planning and
procedures for future external peer review of
programs in the National Center on Birth
Defects and Developmental Disabilities, and
the National Center for Chronic Disease
Prevention and Health Promotion. The BSC
will also discuss results of its review of the
National Center for Chronic Disease
Prevention and Health Promotion as an
organizational unit at CDC.
Providing Oral or Written Comments: It is
the policy of the BSC, CCHP to provide a
brief period for oral public comments. In
general, each individual or group requesting
to make an oral presentation will be limited
to a total time of five minutes if time permits.
Contact Person for Additional Information:
Karen Steinberg, PhD, Senior Science Officer,
Coordinating Center for Health Promotion,
CDC, 4770 Buford Highway, NE., Mailstop E–
70, Atlanta, Georgia 30341; telephone (404)
498–6700; fax (404) 498–6880; or via e-mail
at Karen.Steinberg@cdc.hhs.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
CDC and the Agency for Toxic Substances
and Disease Registry.
Dated: June 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–13757 Filed 6–10–09; 8:45 am]
Dated: June 4, 2009.
Lorenzo Falgiano,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E9–13692 Filed 6–10–09; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4163–18–P
VerDate Nov<24>2008
16:37 Jun 10, 2009
Jkt 217001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\11JNN1.SGM
11JNN1
Agencies
[Federal Register Volume 74, Number 111 (Thursday, June 11, 2009)]
[Notices]
[Page 27805]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-13692]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Coordinating Center for Health
Promotion (BSC, CCHP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 8:30 a.m.-5 p.m., July 1, 2009.
Place: CDC, 1825 Century Boulevard, NE., Room 1042, Atlanta,
Georgia 30345.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 75 people.
Purpose: This BSC is charged with providing advice and guidance
to the Secretary of Health and Human Services, the Director of CDC,
and the Director of CCHP concerning strategies and goals for the
programs and research within the National Center on Birth Defects
and Developmental Disabilities and the National Center for Chronic
Disease Prevention and Health Promotion.
Matters To Be Discussed: The agenda will include a review and
discussion of charges to the BSC Work Groups. The Work Group
projects include strategic planning and procedures for future
external peer review of programs in the National Center on Birth
Defects and Developmental Disabilities, and the National Center for
Chronic Disease Prevention and Health Promotion. The BSC will also
discuss results of its review of the National Center for Chronic
Disease Prevention and Health Promotion as an organizational unit at
CDC.
Providing Oral or Written Comments: It is the policy of the BSC,
CCHP to provide a brief period for oral public comments. In general,
each individual or group requesting to make an oral presentation
will be limited to a total time of five minutes if time permits.
Contact Person for Additional Information: Karen Steinberg, PhD,
Senior Science Officer, Coordinating Center for Health Promotion,
CDC, 4770 Buford Highway, NE., Mailstop E-70, Atlanta, Georgia
30341; telephone (404) 498-6700; fax (404) 498-6880; or via e-mail
at Karen.Steinberg@cdc.hhs.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for CDC and the Agency for Toxic Substances and Disease
Registry.
Dated: June 4, 2009.
Lorenzo Falgiano,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E9-13692 Filed 6-10-09; 8:45 am]
BILLING CODE 4163-18-P